null
US
Sign In
Sign Up for Free
Sign Up
We have detected that Javascript is not enabled in your browser. The dynamic nature of our site means that Javascript must be enabled to function properly. Please read our
terms and conditions
for more information.
Next up
Copy and Edit
You need to log in to complete this action!
Register for Free
292017
General Anaesthetic Agents
Description
Doctorate Anaesthesia Mind Map on General Anaesthetic Agents, created by melian.yates on 21/10/2013.
No tags specified
anaesthesia
anaesthesia
doctorate
Mind Map by
melian.yates
, updated more than 1 year ago
More
Less
Created by
melian.yates
about 11 years ago
154
0
0
Resource summary
General Anaesthetic Agents
General Anaesthesia
Unconsciousness
Analgesia
Muscle relaxation
Anaesthetics
Interaction w/ ligand gated channels
GABAa
Glycine receptor
NMDA
Nicotenic Acetylcholine receptor
Potency correlated to Lipid solubility
Injectable
More action on Brain
Minimal Equipment required
Some require ventilation
No pollution from Gases & Inhalation agents
Recovery relies on Redistribution & Metabolism
Not all drugs are suitable for maintenance
Induction
Short procedures
Maintenance
TIVA
Incremental doses
Continuous rate infusion (CRI)
Supplementation to Inhalational Anaesthesia
Long term sedation in ICU
Tx of Status Epilepticus
Absorption
IV (Most)
Cause loss of consciousness in 1 injection site - brain circulation time
Exception: Ketamine
IM
IP
SC
Intra- animal...
Ideal Properties
No drugs have all Ideal characteristics
Drugs
Barbituates
Derivatives of Barbituric Acid
Thiopental
Used most often in Clinical Practice
Not licensed
Absorption
Na+ salt formulation
Alkaline solution (pH: 10.5)
Very irritant on Perivascular injection
Necrosis!
If accidental Extravascular injection
Dilute w/ sterile saline
Hypoproteinaemia: Reduced Dose
Distribution
Ultra-short acting
Rapid loss of Consciousness
Crosses Placenta
Side Effects
Dose dep. Resp. depression
Apnoea (possible) after induction
CV depression
Hypotension
Reduction of myocardial contractility
Reduces SVR
Compensatory Tachycardia possible
Ventricular Arrhythmias possible
Sensitizes heart to Catecholamines
CNS
Poor muscle relaxation
NO Analgesic properties (Hyperalgesia)
Anti-convulsant
Decreases Intracranial pressure
Cheap
Uses
IV induction (Dogs & Cats)
IV Catheter
Premeds decrease dose
Not recommended for Maintanence
Pentobarbital
Not used in clinical practice much anymore - Long recovery time
Licensed for Euthanasia of small animals and cattle
Oxygen analogue of Thiopental
Absorption
Soluble in H20 - Unstable
Presented in Propylene Glycol
IV (IP)
Distribution
Slow Onset (Max effects)
Long duration of action
Metabolism
Rapid (Sheep, Goats & Horses)
Elimination
Low Clearance: Dogs, Cats & Pigs
NOT recommended for Anaesthesia
Phenobarbital
Methohexital
Not used much in clinical practice yet
Low doses: Sedatives & Hypnotics
Higher doses: Anaesthetic agents
Slow onset & prolonged action
Increased Lipid Solubility
Increases Potency
Rapid onset of action
Shortens duration of action
C5: Increasing carbon chain
Branched chains e.g. thio, metho
Double/triple bonds
C2: Replacing O with S
e.g. thio
Added phenyl group confers Anti-convulsant properties
Ex. Phenobarbital
Methohexital > Thiopental > Pentobarbital
pKa & Protein binding
Ex. Thiopental
pKa = 7.6 (61% unionized @ pH 7.4)
PPB: 85%
Only unionized unbound drug is free to cross membranes
Lipid soluble drugs cross faster
Distribution
Vd: Large (> 1L/kg)
Rapid distribution to tissues
Accumulation in Fatty tissues
Redistribution important for Recovery
Drug injected into circulation
Distribution to highly vascularized tissues (secs)
[Thiopental] in brain reaches high level quickly after injection
Above yellow line: Unconsciousness
Below yellow line: Consciousness
Takes longer to equilibriate with tissues
Fat poorly perfused (vs. muscle, etc.) takes longest to equilibriate w/ blood
Metabolism
Liver
Slow: Cats, Dogs, Horses
Fast: Ruminants
Oxidation & Desulfation
Prolonged Recovery
Large Doses
Repeated Doses
Accumulation: Repeated administration of Thiopental
Note: Greyhounds
Phenols
Propofol
Absorption
White aqueous/oil emulsion - soybean oil, egg lecithin & glycerol
Lipid formulation - Very good culture medium
Lipid free micro-emulsion, antimicrobial preservative
IV
Non-irritant Extravascularly
Pain on injection
Crosses Placenta
Dose given to Effect
Distribution
Very lipid soluble
Almost entirely unionized at pH: 7.4
PPB: 98%
Rapid induction
Vd: Large (>4L/kg)
Metabolism
Much higher metabolism than Thiopental
Better Pharmakinetics for Repeated Doses
Can infuse for many Hrs (Dog)
I.e. Rapid recovery
Liver
Quinol sulfate & Glucuronide conjugates
Note: Cats
Extrahepatic Clearance
Lungs, Kidneys, Blood
Elimination
Rapid Clearance (10-20x faster than Thiopental)
Licensed in Dogs & Cats
Side Effects
Dose dependent Resp. depression
Post- induction Anpnoea > Thiopental
Post- induction cyanosis
Due to opening of shunts in the lungs
Concern if existing respiratory compromise
Transient - improves w/ intubation & O2
Administer SLOWLY
Dose dependent cardiovascular depression
Reduced SVR
No Compensatory Tachycardia
Dose Dependent
High Doses: More pronounced
Effects
Not Arrhytmogenic & does not sensitize heart to Catecholamines
Occasional Muscle twitching or Opistotonus
Can cause Overdose
Usually good muscle relaxation
Decreases Intracranial pressure
Bronchodilation
Anti-convulsant
Low Doses: Sedation in ICU
Uses
Same day, Short Procedures
TIVA (Dogs)
Rabbits, birds, reptiles
Dose decreased by pre-med
Cyclohexanones
Derivatives of Phencyclidine
LSD, Ectasy
Ketamine
Racemic mixture
S(+) more potent
R(-) More cardiac depression & delirium
Licensed Dogs, Cats, Horses, non-human Primates
Absorption
Pain on IM Injection
IV
SC
IP
MM
Mucous membranes
Health & Safety concerns
Distribution
Rapid after IV
PPB: 25-30%
Accumulation possible - Not as quickly as Thiopental
Longer than other Injectables, changes conformation post-injection before crossing BBB
Placental transfer
Metabolism
Liver
Enzymatic induction
Elimination
Kidneys (Urine)
Active Metabolite ( Norketamine)
CNS
NMDA receptor antagonist
Nicotinic, muscarinic, opiod, monoaminergic receptors
Anti-hyperalgesic properties
Reduces MAC
Unconsciousness
Dissociative Anaesthesia
Should NEVER be given on it's own (+ Sedative)
Cranial nerve reflexes maintained
Uses
Chronic pain
Horses: (after alpha 2 agonist)
Induction
Top-up/ Maintenance
Cats & Dogs: Combined with ACP, alpha 2 agonists, opiods, benziadiazepines
Cattle, sheep, pigs
Small mammals, birds & exotics
CVS
Increased sympathetic tone
Increased HR & Contractility
Increased CO & ABP
Increased mVO2
Direct -ve Inotropic Effect
Resp.
Laryngeal & Pharangeal reflexes maintained
Transient resp. depression
Apneustic pattern
Bronchodilation
Side Effects
Increased ICP, CMRO2, IOP & Mydriasis
Seizures possible
Increased Salivation
Muscle rigidity & spontaneous muscle movements common
Dissociative Anaesthesia
Maintains reflexes
Analgesia
Steroids
Alphaxalone
+ Alphadalone (Saffan)
Weak anaesthetic
Increases solubility of Alphaxalone
Small mammals & birds
GABAa receptor binding
Absorption
Viscous solution
Cremophor EL
Causes Histamine release
Do NOT use in Dogs
Potentially fatal Anaphylactoid Rxn
Oedema & flushing of paws
Tx w/ antihistamines, corticosteroids
IV & IM
Non-irritant
Can be topped-up
TIVA
No bacteriostatic agent
Preceiptates (refridgerated)
Distribution
Rapid Onset (IV): 5-20 min
Lower doses: Sedation (IM)
PPB: < 50%
Top-up (IV): Induction
Metabolism
Liver
High therapeutic index
CVS
Transient Hypotension
Resp.
Resp. depression (Dose dependent)
CNS
Muscle relaxation
Twitching (Recovery)
Potent anaesthetic
No cremaphor
No Histamine release
Not irritant if extravascular
IM, CRI
Licensed for Dog & Cat
Premeds Imp.
Very expensive
Progesterone derivatives
Etomidine
GABAa receptors
Absorption
Propylene glycol + H2O mixture
Soybean oil, glycerol egg
Distribution
PPB: 75%
Rapid Onset
Metabloism
No accumulation
Hepatic & Plasmatic esterases
Inactive metabolites
Etomidate
Not licensed in animals
Expensive
Minimal cardiovascular effects
Suitable for animals w/ CV problems
Minimal effect on ICP, CPP, CBF
Minimal Resp. depression
Inhibition of Cortisol synthesis
Inhalation
More action on spinal cord
Rapid recovery after hrs of maintenance
No (or little) metabolism of drugs
More equipment needed
Need to scavenge
Media attachments
Ideal_properties_injectable_anaesthestics (image/png)
Barbituates (image/png)
Thiopental_conc._levels (image/png)
Thiopental_repeated_injection (image/png)
Show full summary
Hide full summary
Want to create your own
Mind Maps
for
free
with GoConqr?
Learn more
.
Similar
ANZCA Part 2 MCQs - 2015
Branden Emmerson
Tissue engineering: Case 6
Bhavi Mistry
ANZCA Part 2 2016
Branden Emmerson
Peri-operative Accidents & Emergencies
melian.yates
Conditions for Surgical Anaesthesia
melian.yates
Inhalation Anaesthetics
melian.yates
Sedatives
melian.yates
Analgesics
melian.yates
Surgical Muscle Relaxation
melian.yates
NS 43 - anaesthesia
Erica Lai
Tips for Succeeding on the Day of the Exam
Jonathan Moore
Browse Library